Aurinia Pharmaceuticals Inc. (AUPH) Free cash flow 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$135.4MFY2025 · since FY2018: -$51.7M → $135.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $135.4M | +207.0% |
| FY2024 | $44.1M | +229.0% |
| FY2023 | -$34.2M | +57.2% |
| FY2022 | -$79.8M | +49.5% |
| FY2021 | -$158.0M | -109.2% |
| FY2020 | -$75.5M | -18.6% |
| FY2019 | -$63.7M | -23.2% |
| FY2018 | -$51.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Gross marginAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →